Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands

Mirjam J. Knol, Gertjan H. J. Wagenvoort, Elisabeth A. M. Sanders, Karin Elberse, Bart J. Vlaminckx, Hester E. de Melker, Arie van der Ende

Research output: Contribution to journalArticleAcademicpeer-review

63 Citations (Scopus)

Abstract

Three years after a 7-valent pneumococcal conjugate vaccine was replaced by a 10-valent pneumococcal conjugate vaccine in the Netherlands, we observed a decrease in incidence of invasive pneumococcal disease caused by Streptococcus pneumoniae serotypes 1, 5, and 7F. Our data do not support or exclude cross-protection against serotype 19A
Original languageEnglish
Pages (from-to)2040-2044
JournalEmerging infectious diseases
Volume21
Issue number11
DOIs
Publication statusPublished - 2015

Cite this